Lactotripeptides: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Added a citation where necessary, and supplemented variance in studies with information from a recent Cochrane systematic review.
m Journal cites: format journal names, using AWB (11880)
Line 1: Line 1:
'''Lactotripeptides''' are two naturally occurring milk [[peptides]]: [[Isoleucine]]-[[Proline]]-Proline (IPP) and [[Valine]]-Proline-Proline (VPP). These lactotripeptides are derived from [[casein]], which is a [[milk protein]] also found in dairy products. Although most normal dairy products contain lactotripeptides, they are inactive within the original milk proteins. Dairy peptides can be effectively released through enzymatic predigestion &ndash; a process by which milk protein is enzymatically broken down into smaller pieces. Some clinical studies have suggested that these lactotripeptides help promote healthy blood pressure levels as part of a healthy diet and lifestyle.<ref name=pmid19061526>{{cite journal |author=Boelsma E, Kloek J |title=Lactotripeptides and antihypertensive effects: a critical review |journal=The British Journal of Nutrition |volume=101 |issue=6 |pages=776–86 |date=March 2009 |pmid=19061526 |doi=10.1017/S0007114508137722}}</ref><ref name="Pripp AH 2008">{{cite journal |author=Pripp AH |title=Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials |journal=Food & Nutrition Research |volume=52 |issue= |pages= |year=2008 |pmid=19109662 |pmc=2596738 |doi=10.3402/fnr.v52i0.1641}}</ref><ref>{{cite journal |author=Xu JY, Qin LQ, Wang PY, Li W, Chang C |title=Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials |journal=Nutrition (Burbank, Los Angeles County, Calif.) |volume=24 |issue=10 |pages=933–40 |date=October 2008 |pmid=18562172 |doi=10.1016/j.nut.2008.04.004}}</ref><ref>{{cite journal |author=Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y |title=Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension |journal=Journal of the American College of Nutrition |volume=24 |issue=4 |pages=257–65 |date=August 2005 |pmid=16093403 |url=http://www.jacn.org/cgi/pmidlookup?view=long&pmid=16093403 |doi=10.1080/07315724.2005.10719473}}</ref><ref>{{cite journal |author=Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TM, Kloek J |title=Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation |journal=The Journal of Nutrition |volume=137 |issue=4 |pages=953–8 |date=April 2007 |pmid=17374660 |url=http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=17374660}}</ref><ref>{{cite journal |author=Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T |title=A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects |journal=The American Journal of Clinical Nutrition |volume=64 |issue=5 |pages=767–71 |date=November 1996 |pmid=8901799 |url=http://www.ajcn.org/cgi/pmidlookup?view=long&pmid=8901799}}</ref><ref>Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T. [http://sciencelinks.jp/j-east/article/200208/000020020802A0144066.php Clinical Effects of New Sour Milk Drink in Mild or Moderate Hypertensive Subjects].J New Rem & Clin 2002;51:61-9.</ref><ref>{{cite journal |author=Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M, Korpela R |title=Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement |journal=American Journal of Hypertension |volume=18 |issue=12 Pt 1 |pages=1600–5 |date=December 2005 |pmid=16364832 |doi=10.1016/j.amjhyper.2005.06.006}}</ref><ref>{{cite journal |author=Jauhiainen T, Korpela R |title=Milk peptides and blood pressure |journal=The Journal of Nutrition |volume=137 |issue=3 Suppl 2 |pages=825S–9S |date=March 2007 |pmid=17311982 |url=http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=17311982}}</ref><ref>{{cite journal |author=Masuda O, Nakamura Y, Takano T |title=Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats |journal=The Journal of Nutrition |volume=126 |issue=12 |pages=3063–8 |date=December 1996 |pmid=9001375 |url=http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=9001375}}</ref><ref>{{cite journal |vauthors=Mizuno S, Matsuura K, Gotou T, etal |title=Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension |journal=The British Journal of Nutrition |volume=94 |issue=1 |pages=84–91 |date=July 2005 |pmid=16115337 |doi=10.1079/BJN20051422}}</ref><ref>{{cite journal |vauthors=Mizushima S, Ohshige K, Watanabe J, etal |title=Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men |journal=American Journal of Hypertension |volume=17 |issue=8 |pages=701–6 |date=August 2004 |pmid=15288885 |doi=10.1016/j.amjhyper.2004.03.674}}</ref><ref>{{cite journal |vauthors=Sano J, Ohki K, Higuchi T, etal |title=Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension |journal=Journal of Medicinal Food |volume=8 |issue=4 |pages=423–30 |year=2005 |pmid=16379551 |doi=10.1089/jmf.2005.8.423}}</ref><ref>{{cite journal |author=Seppo L, Jauhiainen T, Poussa T, Korpela R |title=A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects |journal=The American Journal of Clinical Nutrition |volume=77 |issue=2 |pages=326–30 |date=February 2003 |pmid=12540390 |url=http://www.ajcn.org/cgi/pmidlookup?view=long&pmid=12540390}}</ref><ref>{{cite journal |vauthors=Tuomilehto J, Lindström J, Hyyrynen J, etal |title=Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension |journal=Journal of Human Hypertension |volume=18 |issue=11 |pages=795–802 |date=November 2004 |pmid=15175633 |doi=10.1038/sj.jhh.1001745}}</ref> However, other clinical trials have seen no effects from these compounds.<ref name=Engberink>{{cite journal |author=Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM |title=Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial |journal=Hypertension |volume=51 |issue=2 |pages=399–405 |date=February 2008 |pmid=18086944 |doi=10.1161/HYPERTENSIONAHA.107.098988}}</ref><ref>Usinger L, Reimer C, Ibsen H. Fermented milk for hypertension. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008118. DOI: 10.1002/14651858.CD008118.pub2.</ref>
'''Lactotripeptides''' are two naturally occurring milk [[peptides]]: [[Isoleucine]]-[[Proline]]-Proline (IPP) and [[Valine]]-Proline-Proline (VPP). These lactotripeptides are derived from [[casein]], which is a [[milk protein]] also found in dairy products. Although most normal dairy products contain lactotripeptides, they are inactive within the original milk proteins. Dairy peptides can be effectively released through enzymatic predigestion &ndash; a process by which milk protein is enzymatically broken down into smaller pieces. Some clinical studies have suggested that these lactotripeptides help promote healthy blood pressure levels as part of a healthy diet and lifestyle.<ref name=pmid19061526>{{cite journal |author=Boelsma E, Kloek J |title=Lactotripeptides and antihypertensive effects: a critical review |journal=The British Journal of Nutrition |volume=101 |issue=6 |pages=776–86 |date=March 2009 |pmid=19061526 |doi=10.1017/S0007114508137722}}</ref><ref name="Pripp AH 2008">{{cite journal |author=Pripp AH |title=Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials |journal=Food & Nutrition Research |volume=52 |issue= |pages= |year=2008 |pmid=19109662 |pmc=2596738 |doi=10.3402/fnr.v52i0.1641}}</ref><ref>{{cite journal |author=Xu JY, Qin LQ, Wang PY, Li W, Chang C |title=Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials |journal=Nutrition (Burbank, Los Angeles County, Calif.) |volume=24 |issue=10 |pages=933–40 |date=October 2008 |pmid=18562172 |doi=10.1016/j.nut.2008.04.004}}</ref><ref>{{cite journal |author=Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y |title=Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension |journal=Journal of the American College of Nutrition |volume=24 |issue=4 |pages=257–65 |date=August 2005 |pmid=16093403 |url=http://www.jacn.org/cgi/pmidlookup?view=long&pmid=16093403 |doi=10.1080/07315724.2005.10719473}}</ref><ref>{{cite journal |author=Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TM, Kloek J |title=Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation |journal=The Journal of Nutrition |volume=137 |issue=4 |pages=953–8 |date=April 2007 |pmid=17374660 |url=http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=17374660}}</ref><ref>{{cite journal |author=Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T |title=A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects |journal=The American Journal of Clinical Nutrition |volume=64 |issue=5 |pages=767–71 |date=November 1996 |pmid=8901799 |url=http://www.ajcn.org/cgi/pmidlookup?view=long&pmid=8901799}}</ref><ref>Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T. [http://sciencelinks.jp/j-east/article/200208/000020020802A0144066.php Clinical Effects of New Sour Milk Drink in Mild or Moderate Hypertensive Subjects].J New Rem & Clin 2002;51:61-9.</ref><ref>{{cite journal |author=Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M, Korpela R |title=Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement |journal=American Journal of Hypertension |volume=18 |issue=12 Pt 1 |pages=1600–5 |date=December 2005 |pmid=16364832 |doi=10.1016/j.amjhyper.2005.06.006}}</ref><ref>{{cite journal |author=Jauhiainen T, Korpela R |title=Milk peptides and blood pressure |journal=The Journal of Nutrition |volume=137 |issue=3 Suppl 2 |pages=825S–9S |date=March 2007 |pmid=17311982 |url=http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=17311982}}</ref><ref>{{cite journal |author=Masuda O, Nakamura Y, Takano T |title=Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats |journal=The Journal of Nutrition |volume=126 |issue=12 |pages=3063–8 |date=December 1996 |pmid=9001375 |url=http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=9001375}}</ref><ref>{{cite journal |vauthors=Mizuno S, Matsuura K, Gotou T, etal |title=Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension |journal=The British Journal of Nutrition |volume=94 |issue=1 |pages=84–91 |date=July 2005 |pmid=16115337 |doi=10.1079/BJN20051422}}</ref><ref>{{cite journal |vauthors=Mizushima S, Ohshige K, Watanabe J, etal |title=Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men |journal=American Journal of Hypertension |volume=17 |issue=8 |pages=701–6 |date=August 2004 |pmid=15288885 |doi=10.1016/j.amjhyper.2004.03.674}}</ref><ref>{{cite journal |vauthors=Sano J, Ohki K, Higuchi T, etal |title=Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension |journal=Journal of Medicinal Food |volume=8 |issue=4 |pages=423–30 |year=2005 |pmid=16379551 |doi=10.1089/jmf.2005.8.423}}</ref><ref>{{cite journal |author=Seppo L, Jauhiainen T, Poussa T, Korpela R |title=A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects |journal=The American Journal of Clinical Nutrition |volume=77 |issue=2 |pages=326–30 |date=February 2003 |pmid=12540390 |url=http://www.ajcn.org/cgi/pmidlookup?view=long&pmid=12540390}}</ref><ref>{{cite journal |vauthors=Tuomilehto J, Lindström J, Hyyrynen J, etal |title=Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension |journal=Journal of Human Hypertension |volume=18 |issue=11 |pages=795–802 |date=November 2004 |pmid=15175633 |doi=10.1038/sj.jhh.1001745}}</ref> However, other clinical trials have seen no effects from these compounds.<ref name=Engberink>{{cite journal |author=Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM |title=Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial |journal=Hypertension |volume=51 |issue=2 |pages=399–405 |date=February 2008 |pmid=18086944 |doi=10.1161/HYPERTENSIONAHA.107.098988}}</ref><ref name="Usinger L 2012">{{cite journal | author = Usinger L, Reimer C, Ibsen H | year = 2012 | title = Fermented milk for hypertension | url = | journal = Cochrane Database of Systematic Reviews | volume = | issue = | page = CD008118 | doi = 10.1002/14651858.CD008118.pub2 }}</ref>


== Proposed mechanism ==
== Proposed mechanism ==
Line 5: Line 5:


== Clinical trials ==
== Clinical trials ==
Several human trials aimed to evaluate the effect of lactotripeptides on blood pressure. Some trials show a blood pressure-lowering effect of lactotripeptides in people with mild to moderate hypertension,<ref name=pmid19061526/><ref name="Pripp AH 2008"/><ref>{{cite journal |author=Xu JY, Qin LQ, Wang PY, Li W, Chang C |title=Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials |journal=Nutrition |volume=24 |issue=10 |pages=933–40 |date=October 2008 |pmid=18562172 |doi=10.1016/j.nut.2008.04.004}}</ref> however others see no effect from these peptides.<ref name=Engberink/><ref>{{cite journal |author=van Mierlo LA, Koning MM, van der Zander K, Draijer R |title=Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies |journal=The American Journal of Clinical Nutrition |volume=89 |issue=2 |pages=617–23 |date=February 2009 |pmid=19106238 |doi=10.3945/ajcn.2008.26918}}</ref><ref>{{cite journal |author=van der Zander K, Bots ML, Bak AA, Koning MM, de Leeuw PW |title=Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects |journal=The American Journal of Clinical Nutrition |volume=88 |issue=6 |pages=1697–702 |date=December 2008 |pmid=19064533 |doi=10.3945/ajcn.2008.26003}}</ref> A recent systematic review of the literature found no confirmed ACE-inhibitor effects in humans, as well as no conclusive evidence for lactotripeptides as a successful intervention; the meta-analysis cited heterogeneity in methodology and lack of inclusion of recent larger studies by prior meta-analyses to account for the variance between studies.<ref>Usinger L, Reimer C, Ibsen H. Fermented milk for hypertension. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008118. DOI: 10.1002/14651858.CD008118.pub2.</ref>
Several human trials aimed to evaluate the effect of lactotripeptides on blood pressure. Some trials show a blood pressure-lowering effect of lactotripeptides in people with mild to moderate hypertension,<ref name=pmid19061526/><ref name="Pripp AH 2008"/><ref>{{cite journal |author=Xu JY, Qin LQ, Wang PY, Li W, Chang C |title=Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials |journal=Nutrition |volume=24 |issue=10 |pages=933–40 |date=October 2008 |pmid=18562172 |doi=10.1016/j.nut.2008.04.004}}</ref> however others see no effect from these peptides.<ref name=Engberink/><ref>{{cite journal |author=van Mierlo LA, Koning MM, van der Zander K, Draijer R |title=Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies |journal=The American Journal of Clinical Nutrition |volume=89 |issue=2 |pages=617–23 |date=February 2009 |pmid=19106238 |doi=10.3945/ajcn.2008.26918}}</ref><ref>{{cite journal |author=van der Zander K, Bots ML, Bak AA, Koning MM, de Leeuw PW |title=Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects |journal=The American Journal of Clinical Nutrition |volume=88 |issue=6 |pages=1697–702 |date=December 2008 |pmid=19064533 |doi=10.3945/ajcn.2008.26003}}</ref> A recent systematic review of the literature found no confirmed ACE-inhibitor effects in humans, as well as no conclusive evidence for lactotripeptides as a successful intervention; the meta-analysis cited heterogeneity in methodology and lack of inclusion of recent larger studies by prior meta-analyses to account for the variance between studies.<ref name="Usinger L 2012"/>


==References==
==References==

Revision as of 18:26, 9 February 2016

Lactotripeptides are two naturally occurring milk peptides: Isoleucine-Proline-Proline (IPP) and Valine-Proline-Proline (VPP). These lactotripeptides are derived from casein, which is a milk protein also found in dairy products. Although most normal dairy products contain lactotripeptides, they are inactive within the original milk proteins. Dairy peptides can be effectively released through enzymatic predigestion – a process by which milk protein is enzymatically broken down into smaller pieces. Some clinical studies have suggested that these lactotripeptides help promote healthy blood pressure levels as part of a healthy diet and lifestyle.[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15] However, other clinical trials have seen no effects from these compounds.[16][17]

Proposed mechanism

Dairy peptides are proposed to inhibit the activity of the angiotensin-converting enzyme (ACE). ACE is part of the renin-angiotensin system — a natural mechanism that helps regulate blood pressure in the body. In certain individuals, the renin-angiotensin system can become overactive, often due to stress, an unhealthy diet, and/or unhealthy lifestyle. Under such conditions, ACE becomes overactive and converts more angiotensin I into angiotensin II. Angiotensin II causes blood vessels to constrict, and so increases blood pressure, which has potential to lead to hypertension. But, when ACE activity is inhibited, the formation of angiotensin II is reduced. This then helps the blood vessels to relax and expand back to a normal healthy state, so blood pressure is lowered.

Clinical trials

Several human trials aimed to evaluate the effect of lactotripeptides on blood pressure. Some trials show a blood pressure-lowering effect of lactotripeptides in people with mild to moderate hypertension,[1][2][18] however others see no effect from these peptides.[16][19][20] A recent systematic review of the literature found no confirmed ACE-inhibitor effects in humans, as well as no conclusive evidence for lactotripeptides as a successful intervention; the meta-analysis cited heterogeneity in methodology and lack of inclusion of recent larger studies by prior meta-analyses to account for the variance between studies.[17]

References

  1. ^ a b Boelsma E, Kloek J (March 2009). "Lactotripeptides and antihypertensive effects: a critical review". The British Journal of Nutrition. 101 (6): 776–86. doi:10.1017/S0007114508137722. PMID 19061526.
  2. ^ a b Pripp AH (2008). "Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials". Food & Nutrition Research. 52. doi:10.3402/fnr.v52i0.1641. PMC 2596738. PMID 19109662.
  3. ^ Xu JY, Qin LQ, Wang PY, Li W, Chang C (October 2008). "Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials". Nutrition (Burbank, Los Angeles County, Calif.). 24 (10): 933–40. doi:10.1016/j.nut.2008.04.004. PMID 18562172.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y (August 2005). "Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension". Journal of the American College of Nutrition. 24 (4): 257–65. doi:10.1080/07315724.2005.10719473. PMID 16093403.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TM, Kloek J (April 2007). "Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation". The Journal of Nutrition. 137 (4): 953–8. PMID 17374660.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T (November 1996). "A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects". The American Journal of Clinical Nutrition. 64 (5): 767–71. PMID 8901799.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T. Clinical Effects of New Sour Milk Drink in Mild or Moderate Hypertensive Subjects.J New Rem & Clin 2002;51:61-9.
  8. ^ Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M, Korpela R (December 2005). "Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement". American Journal of Hypertension. 18 (12 Pt 1): 1600–5. doi:10.1016/j.amjhyper.2005.06.006. PMID 16364832.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. ^ Jauhiainen T, Korpela R (March 2007). "Milk peptides and blood pressure". The Journal of Nutrition. 137 (3 Suppl 2): 825S–9S. PMID 17311982.
  10. ^ Masuda O, Nakamura Y, Takano T (December 1996). "Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats". The Journal of Nutrition. 126 (12): 3063–8. PMID 9001375.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  11. ^ Mizuno S, Matsuura K, Gotou T, et al. (July 2005). "Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension". The British Journal of Nutrition. 94 (1): 84–91. doi:10.1079/BJN20051422. PMID 16115337.
  12. ^ Mizushima S, Ohshige K, Watanabe J, et al. (August 2004). "Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men". American Journal of Hypertension. 17 (8): 701–6. doi:10.1016/j.amjhyper.2004.03.674. PMID 15288885.
  13. ^ Sano J, Ohki K, Higuchi T, et al. (2005). "Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension". Journal of Medicinal Food. 8 (4): 423–30. doi:10.1089/jmf.2005.8.423. PMID 16379551.
  14. ^ Seppo L, Jauhiainen T, Poussa T, Korpela R (February 2003). "A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects". The American Journal of Clinical Nutrition. 77 (2): 326–30. PMID 12540390.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ^ Tuomilehto J, Lindström J, Hyyrynen J, et al. (November 2004). "Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension". Journal of Human Hypertension. 18 (11): 795–802. doi:10.1038/sj.jhh.1001745. PMID 15175633.
  16. ^ a b Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM (February 2008). "Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial". Hypertension. 51 (2): 399–405. doi:10.1161/HYPERTENSIONAHA.107.098988. PMID 18086944.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  17. ^ a b Usinger L, Reimer C, Ibsen H (2012). "Fermented milk for hypertension". Cochrane Database of Systematic Reviews: CD008118. doi:10.1002/14651858.CD008118.pub2.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. ^ Xu JY, Qin LQ, Wang PY, Li W, Chang C (October 2008). "Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials". Nutrition. 24 (10): 933–40. doi:10.1016/j.nut.2008.04.004. PMID 18562172.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. ^ van Mierlo LA, Koning MM, van der Zander K, Draijer R (February 2009). "Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies". The American Journal of Clinical Nutrition. 89 (2): 617–23. doi:10.3945/ajcn.2008.26918. PMID 19106238.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  20. ^ van der Zander K, Bots ML, Bak AA, Koning MM, de Leeuw PW (December 2008). "Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects". The American Journal of Clinical Nutrition. 88 (6): 1697–702. doi:10.3945/ajcn.2008.26003. PMID 19064533.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Lactotripeptides&oldid=704125642"